JP Morgan Chase
SONM icon

JP Morgan Chase’s DNA X Inc SONM Stock Holding History

JP Morgan Chase’s Portfolio SONM Stock Details SONM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10
Closed -$226 – 7701
2025
Q2 		$226 Buy
+10
New +$247 ﹤0.01% 6774
2025
Q1 		– Hold
0
– – – 7174
2024
Q4 		– Hold
0
– – – 7276
2024
Q3 		– Hold
0
– – – 7264
2024
Q2 		– Hold
0
– – – 7001
2024
Q1 		– Hold
0
– – – 7118
2023
Q4 		– Hold
0
– – – 7339
2023
Q3 		– Hold
0
– – – 7234
2021
Q4 		– Hold
0
– – – 6936
2021
Q3 		– Hold
0
– – – 6774
2021
Q2 		– Hold
0
– – – 6591
2021
Q1 		– Sell
-2
Closed -$3.53K – 6327
2020
Q4 		$3K Hold
2
– – ﹤0.01% 5494
2020
Q3 		$3K Hold
2
– – ﹤0.01% 5367
2020
Q2 		$3K Sell
2
-10
-83% -$16K ﹤0.01% 5236
2020
Q1 		$15K Buy
12
+5
+71% +$24K ﹤0.01% 5003
2019
Q4 		$45K Buy
7
+6
+600% +$29.6K ﹤0.01% 5162
2019
Q3 		$4K Hold
1
– – ﹤0.01% 5593
2019
Q2 		$13K Buy
+1
New +$25.4K ﹤0.01% 5523

Other funds holding SONM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DWM
Dogwood Wealth Management Lenexa, Kansas $253M AUM 19.41% 1-Year Est. Return

JP Morgan Chase's SONM Position: Q3 2025 in Review

JP Morgan Chase sold out of DNA X Inc (SONM) in Q3 2025, closing a stake of 10 shares — an estimated $226 sold.

JP Morgan Chase first reported a position in SONM in Q2 2019 and held it in 8 quarters. The position peaked at $45K in Q4 2019. 12 funds tracked by Wall St. Rank hold SONM as of Q3 2025.

  • JP Morgan Chase reported no remaining DNA X Inc position as of Q3 2025 after selling out during the quarter.
  • JP Morgan Chase sold 10 DNA X Inc shares in Q3 2025, an estimated $226.
  • JP Morgan Chase first reported a position in DNA X Inc in Q2 2019 and held it in 8 quarters.
  • JP Morgan Chase's DNA X Inc position peaked at $45K in Q4 2019.
  • 12 funds tracked by Wall St. Rank held DNA X Inc as of Q3 2025.

Based on JP Morgan Chase's 13F filing for Q3 2025, filed 7 Nov 2025.